[Experimental study on the prevention of vasospasm following subarachnoid hemorrhage by a thromboxane A2 synthetase inhibitor, OKY-046].
D000179:Acrylates / Q000627:therapeutic use*; D000818:Animals; D004285:Dogs; D002546:Ischemic Attack, Transient / Q000517:prevention & control*; D008689:Methacrylates / Q000627:therapeutic use*; D013345:Subarachnoid Hemorrhage / Q000150:complications*; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors*
D000179:Acrylates; D008689:Methacrylates; D013930:Thromboxane-A Synthase; C034364:ozagrel